Results 131 to 139 of about 8,062 (139)

Synaptic Vesicle Glycoprotein 2C (SV2C) Modulates Dopamine Release and Is Disrupted in Parkinson Disease

Proceedings of the National Academy of Sciences of the United States of America, 2017
Amy R Dunn, Gary W. Miller, Kristen A Stout   +2 more
exaly  

Membrane Protein and Glycoprotein Composition of Beef Brain Synaptic Vesicles

Journal of Neuroscience Research, 1977
T V Waehneldt, Volker Neuhoff, C Richter-Landsberg   +2 more
exaly  

Clathrin Regenerates Synaptic Vesicles From Endosomes

Nature, 2014
Thorsten Trimbuch, Shigeki Watanabe, Marcial Camacho-Perez   +2 more
exaly  

Synaptic Vesicle Glycoprotein 2C: A Role in Parkinson’s Disease

Frontiers in Cellular Neuroscience
Jia Nee Foo, Kah Leong Lim, Chu Hua Chang   +2 more
exaly  

Hydrodynamic Molecular Weight of Solubilized Cholinergic Synaptic Vesicle Glycoprotein ATPase

Journal of Neurochemistry, 1989
Stanley Parsons
exaly  

Synaptic Vesicle Glycoprotein 2C Enhances Vesicular Storage of Dopamine and Counters Dopaminergic Toxicity

European Journal of Neuroscience
Amy R Dunn, Meghan L Bucher, Gary W. Miller   +2 more
exaly  

Synaptic Vesicle Glycoprotein 2A in Serum is an Ideal Biomarker for Early Warning and Early Diagnosis of Alzheimer's Disease

Xiaoling Wang, Xiaomin Zhang, Jing Liu, Jingjing Zhang, Congcong Liu, Yuting Cui, Qiao Song, Yuli Hou, Yaqi Wang, Qian Zhang, Yingzhen Zhang, Yujian Fan, Jianping Jia, Peichang Wang   +13 more
openaire   +1 more source

Exploring the Interactions Between Two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 Isoforms

ACS Chemical Neuroscience
Andrea Varrone, Junhao Li, Sangram Nag
exaly  

Synaptic Vesicle Glycoprotein 2A imaging of non-pharmacological therapies for Pakinson's disease

openaire   +1 more source